thiazoles has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hattori, Y; Kasai, K; Matsumura, M | 1 |
Echizen, H; Oishi, K; Uchida, M; Yamaguchi, T | 1 |
Hokari, A | 1 |
Chang, JH; Kang, TY; Kim, SK; Lee, KJ; Yoo, DH | 1 |
Chen, YR; Efferth, T; Hamm, R; Müller, R; Seo, EJ; Wu, CF; Yang, NS; Zeino, M | 1 |
1 review(s) available for thiazoles and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
[Improved virologic response in chronic hepatitis C treated with peginterferon, ribavirin and add-on drug].
Topics: Antiviral Agents; Cyclosporine; Diterpenes; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fatty Alcohols; Female; Fluvastatin; Hepatitis C, Chronic; Humans; Indoles; Interferon-alpha; Male; Metformin; Nitro Compounds; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Silybin; Silymarin; Thiazoles | 2011 |
4 other study(ies) available for thiazoles and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
Vascular smooth muscle cell activation by C-reactive protein.
Topics: Analysis of Variance; Animals; C-Reactive Protein; Cells, Cultured; Chemokine CCL2; Enzyme Activation; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Indoles; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Pioglitazone; Pyridines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factor AP-1; Transcription Factors | 2003 |
Edaravone, a radical scavenger, may enhance or produce antiproliferative effects of fluvastatin, amlodipine, ozagrel, GF109203X and Y27632 on cultured basilar artery smooth muscle cells.
Topics: Amides; Amlodipine; Animals; Antipyrine; Arteriosclerosis; Basilar Artery; Cell Division; Cell Survival; Cells, Cultured; Drug Synergism; Drug Therapy, Combination; Edaravone; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Free Radical Scavengers; Indoles; Maleimides; Methacrylates; Muscle, Smooth, Vascular; Pyridines; Reactive Oxygen Species; Signal Transduction; Tetrazolium Salts; Thiazoles | 2003 |
Validity of SW982 synovial cell line for studying the drugs against rheumatoid arthritis in fluvastatin-induced apoptosis signaling model.
Topics: Apoptosis; Arthritis, Rheumatoid; Cell Line; Cell Survival; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Membrane Potential, Mitochondrial; Polyisoprenyl Phosphates; Signal Transduction; Synovial Fluid; Tetrazolium Salts; Thiazoles | 2014 |
Induction of cholesterol biosynthesis by archazolid B in T24 bladder cancer cells.
Topics: Cell Line, Tumor; Cell Survival; Cholesterol; Drug Resistance, Neoplasm; Endocytosis; Fatty Acids, Monounsaturated; Fluvastatin; Gene Expression Regulation, Neoplastic; Humans; Indoles; Lipoproteins, LDL; Macrolides; MicroRNAs; Real-Time Polymerase Chain Reaction; Receptors, LDL; Reproducibility of Results; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Protein 2; Thiazoles; Urinary Bladder Neoplasms | 2014 |